Russian Journal of AllergyRussian Journal of Allergy1810-88302686-682XFarmarus Print Media139210.36691/RJA1392Research ArticleModern anti-IgE therapies in children with chronic spontaneous urticaria: clinical casesLarkovaInna A.<p>Senior researcher of Allergy Department, MD</p>inna_larkova@mail.ruhttps://orcid.org/0000-0001-7640-0754RevyakinaVera A.<p>Head of Allergy Department</p>5356797@mail.ruhttps://orcid.org/0000-0002-1149-7927The Federal Research Center for Nutrition, Вiotechnology and Food Safety2912202017485892608202005112020Copyright © 2021, Pharmarus Print Media2021<p>The diagnostics and treatment of chronic urticaria is still a pressing problem for specialists of different profiles. Despite the fact that the first line drugs for urticaria treatment are non-sedating H<sub>1</sub>- antihistamines, there are a number of patients who do not respond to these medications even in their increased doses. This article presents clinical cases of anti-IgE-therapy efficacy in children suffering from urticaria and angioedema.</p>
<p><strong>CONCLUSION:</strong> The clinical cases demonstrate current possibilities of successful and safe anti-IgE-therapy of various clinical manifestations of chronic spontaneous urticaria and angioedema in children.</p>chronic spontaneous urticariaangioedemachildrenanti-IgE-therapyomalizumabmonoclonal antibodyхроническая спонтанная крапивницаангиоотекдетианти-IgE-терапияомализумабмоноклональное антитело[Клиническая аллергология детского возраста с неотложными состояниями / под ред. Балаболкина И.И., Булгаковой В.А. М. : МИА, 2011.][Российская Ассоциация Аллергологов и Клинических Иммунологов. Федеральные клинические рекомендации по диагностике и лечению крапивницы. М., 2018.][Zuberbier T., Aberer W., Asero R., et al. The EAACI/GA²LEN/ EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria // Allergy. 2018. Vol. 73. N 7. P. 1393–1414. doi: 10.1111/all.13397][Horn MP, Pachlopnik JM, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? // FASEB J. 2001. N 12. P. 2268–2274.doi: 10.1096/fj.00-0890hyp][Beck L.A., Bernstein J.A., Maurer M. A review of international recommendations for the diagnosis and management of chronic urticaria // Acta Derm Venereol. 2017. Vol. 97. N 2. P. 149–158. doi: 10.2340/00015555-2496][Maurer М., Rosen K., Hsieh H.J., et al. Оmalizumab for the treatment of chronic idiopathic or spontaneous urticaria // N Engl J Med. 2013. Vol. 368. N 10. P. 924–935.doi: 10.1056/NEJMoa1215372][Rosen K., Maurer M., Hsieh H., et al. Response to: ‘Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal’ // Br J Dermatol. 2014. N 1. P. 15–16. doi: 10.1111/bjd.13075]